These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 26844665)
21. Cardiac ion channel safety profiling on the IonWorks Quattro automated patch clamp system. Cao X; Lee YT; Holmqvist M; Lin Y; Ni Y; Mikhailov D; Zhang H; Hogan C; Zhou L; Lu Q; Digan ME; Urban L; Erdemli G Assay Drug Dev Technol; 2010 Dec; 8(6):766-80. PubMed ID: 21133679 [TBL] [Abstract][Full Text] [Related]
22. Modulation of peripheral Na(+) channels and neuronal firing by n-butyl-p-aminobenzoate. Thériault O; Poulin H; Sculptoreanu A; de Groat WC; O'Leary ME; Chahine M Eur J Pharmacol; 2014 Mar; 727():158-66. PubMed ID: 24486399 [TBL] [Abstract][Full Text] [Related]
23. Functional assay of voltage-gated sodium channels using membrane potential-sensitive dyes. Felix JP; Williams BS; Priest BT; Brochu RM; Dick IE; Warren VA; Yan L; Slaughter RS; Kaczorowski GJ; Smith MM; Garcia ML Assay Drug Dev Technol; 2004 Jun; 2(3):260-8. PubMed ID: 15285907 [TBL] [Abstract][Full Text] [Related]
24. Population patch clamp improves data consistency and success rates in the measurement of ionic currents. Finkel A; Wittel A; Yang N; Handran S; Hughes J; Costantin J J Biomol Screen; 2006 Aug; 11(5):488-96. PubMed ID: 16760372 [TBL] [Abstract][Full Text] [Related]
25. Comparative evaluation of in vitro and in vivo high glucose-induced alterations in voltage-gated tetrodotoxin-resistant sodium channel: Effects attenuated by sodium channel blockers. Kharatmal SB; Singh JN; Sharma SS Neuroscience; 2015 Oct; 305():183-96. PubMed ID: 26255676 [TBL] [Abstract][Full Text] [Related]
26. Use-dependent block by lidocaine but not amitriptyline is more pronounced in tetrodotoxin (TTX)-Resistant Nav1.8 than in TTX-sensitive Na+ channels. Leffler A; Reiprich A; Mohapatra DP; Nau C J Pharmacol Exp Ther; 2007 Jan; 320(1):354-64. PubMed ID: 17005919 [TBL] [Abstract][Full Text] [Related]
27. Assessing use-dependent inhibition of the cardiac Na(+/-) current (I(Na)) in the PatchXpress automated patch clamp. Penniman JR; Kim DC; Salata JJ; Imredy JP J Pharmacol Toxicol Methods; 2010; 62(2):107-18. PubMed ID: 20601018 [TBL] [Abstract][Full Text] [Related]
28. Transfection methods for high-throughput cellular assays of voltage-gated calcium and sodium channels involved in pain. Hasan MM; Ragnarsson L; Cardoso FC; Lewis RJ PLoS One; 2021; 16(3):e0243645. PubMed ID: 33667217 [TBL] [Abstract][Full Text] [Related]
30. Characterization of a hERG screen using the IonWorks HT: comparison to a hERG rubidium efflux screen. Sorota S; Zhang XS; Margulis M; Tucker K; Priestley T Assay Drug Dev Technol; 2005 Feb; 3(1):47-57. PubMed ID: 15798395 [TBL] [Abstract][Full Text] [Related]
31. Novel KCNQ2 channel activators discovered using fluorescence-based and automated patch-clamp-based high-throughput screening techniques. Yue JF; Qiao GH; Liu N; Nan FJ; Gao ZB Acta Pharmacol Sin; 2016 Jan; 37(1):105-10. PubMed ID: 26725738 [TBL] [Abstract][Full Text] [Related]
32. Development of an Electrophysiological Assay for Kv7 Modulators on IonWorks Barracuda. Wilenkin B; Burris KD; Eastwood BJ; Sher E; Williams AC; Priest BT Assay Drug Dev Technol; 2019 Oct; 17(7):310-321. PubMed ID: 31634018 [No Abstract] [Full Text] [Related]
33. Mechanism of inhibition by chlorpromazine of the human pain threshold sodium channel, Na Lee SJ; Kim DH; Hahn SJ; Waxman SG; Choi JS Neurosci Lett; 2017 Feb; 639():1-7. PubMed ID: 28017662 [TBL] [Abstract][Full Text] [Related]
34. Efficient characterization of use-dependent ion channel blockers by real-time monitoring of channel state. Tao H; Guia A; Xie B; Santaana D; Manalo G; Xu J; Ghetti A Assay Drug Dev Technol; 2006 Feb; 4(1):57-64. PubMed ID: 16506889 [TBL] [Abstract][Full Text] [Related]
35. Identification and Characterization of ProTx-III [μ-TRTX-Tp1a], a New Voltage-Gated Sodium Channel Inhibitor from Venom of the Tarantula Thrixopelma pruriens. Cardoso FC; Dekan Z; Rosengren KJ; Erickson A; Vetter I; Deuis JR; Herzig V; Alewood PF; King GF; Lewis RJ Mol Pharmacol; 2015 Aug; 88(2):291-303. PubMed ID: 25979003 [TBL] [Abstract][Full Text] [Related]
36. The effects of A-803467 on cardiac Nav1.5 channels. Han Z; Jiang Y; Xiao F; Cao K; Wang DW Eur J Pharmacol; 2015 May; 754():52-60. PubMed ID: 25701724 [TBL] [Abstract][Full Text] [Related]
37. A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity. Sheets PL; Jackson JO; Waxman SG; Dib-Hajj SD; Cummins TR J Physiol; 2007 Jun; 581(Pt 3):1019-31. PubMed ID: 17430993 [TBL] [Abstract][Full Text] [Related]
38. Carisbamate, a novel neuromodulator, inhibits voltage-gated sodium channels and action potential firing of rat hippocampal neurons. Liu Y; Yohrling GJ; Wang Y; Hutchinson TL; Brenneman DE; Flores CM; Zhao B Epilepsy Res; 2009 Jan; 83(1):66-72. PubMed ID: 19013768 [TBL] [Abstract][Full Text] [Related]
39. Single Residue Substitutions That Confer Voltage-Gated Sodium Ion Channel Subtype Selectivity in the NaV1.7 Inhibitory Peptide GpTx-1. Murray JK; Long J; Zou A; Ligutti J; Andrews KL; Poppe L; Biswas K; Moyer BD; McDonough SI; Miranda LP J Med Chem; 2016 Mar; 59(6):2704-17. PubMed ID: 26890998 [TBL] [Abstract][Full Text] [Related]